RNA

Total RNA was prepared from cell line WM209. WM209 is a metastatic human melanoma cell line that forms flat tight colonies in culture medium. This cell line contains a G12A mutation at position 12 of the N-RAS gene. This cell line also expresses PTEN loss of function including homozygous deletion and is wild type for BRAF, c-KIT and CDK4. WM209 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM209. WM209 is a metastatic human melanoma cell line that forms flat tight colonies in culture medium. This cell line contains a G12A mutation at position 12 of the N-RAS gene. This cell line also expresses PTEN loss of function including homozygous deletion and is wild type for BRAF, c-KIT and CDK4. WM209 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM2090. WM2090 is a metastatic human melanoma cell line. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. WM2090 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM2090. WM2090 is a metastatic human melanoma cell line. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. WM2090 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM2090. WM2090 is a metastatic human melanoma cell line. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. WM2090 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM239A. WM239A is a metastatic human melanoma cell line with thin elongated fibroblastic morphology. This cell line was derived from the same patient as the cell lines WM115, WM266-4, and WM165-1. WM115 cell line originated from the primary tumor, and WM239A, WM165-1 and WM266-4 were from individual lymph-node metastases. The subject (55-year-old female) displayed VGP with a Clark level III tumor with thickness of 2.24mm.This cell line features the specific V600D (Val600Asp) mutation at codon 600 in the BRAF gene. This cell line also expresses PTEN loss of function including hemizygous deletion. WM239A cell line is wild type for N-RAS, c-KIT, and CDK4 genes. WM239A cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM239A. WM239A is a metastatic human melanoma cell line with thin elongated fibroblastic morphology. This cell line was derived from the same patient as the cell lines WM115, WM266-4, and WM165-1. WM115 cell line originated from the primary tumor, and WM239A, WM165-1 and WM266-4 were from individual lymph-node metastases. The subject (55-year-old female) displayed VGP with a Clark level III tumor with thickness of 2.24mm.This cell line features the specific V600D (Val600Asp) mutation at codon 600 in the BRAF gene. This cell line also expresses PTEN loss of function including hemizygous deletion. WM239A cell line is wild type for N-RAS, c-KIT, and CDK4 genes. WM239A cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM239A. WM239A is a metastatic human melanoma cell line with thin elongated fibroblastic morphology. This cell line was derived from the same patient as the cell lines WM115, WM266-4, and WM165-1. WM115 cell line originated from the primary tumor, and WM239A, WM165-1 and WM266-4 were from individual lymph-node metastases. The subject (55-year-old female) displayed VGP with a Clark level III tumor with thickness of 2.24mm.This cell line features the specific V600D (Val600Asp) mutation at codon 600 in the BRAF gene. This cell line also expresses PTEN loss of function including hemizygous deletion. WM239A cell line is wild type for N-RAS, c-KIT, and CDK4 genes. WM239A cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM262. WM262 is a metastatic human melanoma cell line. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. WM262 cells produce xenograft tumors when injected into immunocompromised mice.